6934
HCmed Innovations Co., Ltd. designs, develops, manufactures, and sells mesh nebulizers to deliver liquid medications into the respiratory airways in the United States, Europe and Asia. The company's products include Pulmogine, a vibrating mesh nebulizer to nebulize a range of liquid medications to treat respiratory diseases and their symptoms in children and adults; and AdheResp, a breath-actuate… Read more
Market Cap & Net Worth: 6934 (6934)
6934 (TWO:6934) has a market capitalization of $81.08 Million (NT$2.68 Billion) as of March 19, 2026. Listed on the TWO stock exchange, this Taiwan-based company holds position #21375 globally and #1173 in its home market, demonstrating a -47.60% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying 6934's stock price NT$82.00 by its total outstanding shares 32716762 (32.72 Million).
6934 Market Cap History: 2026 to 2026
6934's market capitalization history from 2026 to 2026. Data shows growth from $81.08 Million to $81.08 Million (0.00% CAGR).
6934 Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how 6934's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of 6934 by Market Capitalization
Companies near 6934 in the global market cap rankings as of March 19, 2026.
Key companies related to 6934 by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #84 globally with a market cap of $187.53 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #151 globally with a market cap of $119.88 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #170 globally with a market cap of $111.60 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #183 globally with a market cap of $105.38 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #84 | Abbott Laboratories | NYSE:ABT | $187.53 Billion | $108.49 |
| #151 | Stryker Corporation | NYSE:SYK | $119.88 Billion | $345.81 |
| #170 | Medtronic PLC | NYSE:MDT | $111.60 Billion | $87.21 |
| #183 | Boston Scientific Corp | NYSE:BSX | $105.38 Billion | $71.28 |
6934 Historical Marketcap From 2026 to 2026
Between 2026 and today, 6934's market cap moved from $81.08 Million to $ 81.08 Million, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | NT$81.08 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 19th, 2026 the market cap of 6934 was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $81.08 Million USD |
| MoneyControl | $81.08 Million USD |
| MarketWatch | $81.08 Million USD |
| marketcap.company | $81.08 Million USD |
| Reuters | $81.08 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.